HOME > TOP STORIES
TOP STORIES
-
BUSINESS Haihe Steps into Japan Oncology Space as CEO Sees Growth Potential
January 10, 2025
-
COMMENTARY Japan Expects to Approve/List 43 Novel Drugs in 2025 Including Ultra-Expensive Gene Therapies
January 9, 2025
-
ORGANIZATION Pharma CEOs Discouraged by Off-Year Revision, but Give Certain Credit to Category-Based Scope
January 9, 2025
-
REGULATORY MHLW Official Reveals Rationales Behind Off-Year Decision, Says PMP Return Is Reasonable
January 8, 2025
-
BUSINESS Daiichi Sankyo to Transfer Avastin Biosimilar to Amgen in Japan
January 8, 2025
-
ORGANIZATION 4-Ministers’ Pact Has Effectively Been Scrapped with 2025 Off-Year Revision Plan: FPMAJ Chair
January 7, 2025
-
ORGANIZATION As 2025 Begins, Industry Leaders Renew Resolve towards Next Reforms
January 6, 2025
-
REGULATORY Japan Approves Zepbound, Qalsody, and Lots More Drugs
December 27, 2024
-
REGULATORY Quality Assurance and Lag/Loss Fight to Form Pillars of PMD Act Amendment
December 27, 2024
-
REGULATORY Chuikyo OKs Outline of FY2025 Off-Year Drug Price Revision
December 26, 2024
-
TRENDS Top 10 PHARMA JAPAN Articles of 2024
December 25, 2024
-
REGULATORY Deferred PMP Cuts Likely to Batter Stelara; 7 Drugs Subject to Rule after LOE
December 24, 2024
-
REGULATORY CEA Expansion, Higher Copay Likely to Be Included in Minister Budget Deal
December 24, 2024
-
COMMENTARY Where Do Japan Drug Makers Stand? A Comparison with Other Industries and Mega Pharma Peers
December 24, 2024
-
REGULATORY Off-Year Price Revision to Hit 53% of Listed Drugs in 2025, Down from 69%
December 23, 2024
-
REGULATORY Three Ministers Agree on Off-Year Drug Price Revision in FY2025
December 20, 2024
-
REGULATORY Japan Set to Settle Off-Year Debate with “x1.0” Threshold for PMP Meds/Generics, “x0.5” for LLPs
December 20, 2024
-
REGULATORY Japan Weighs Tweaking “x0.625” Threshold to Narrow Off-Year Revision Coverage
December 19, 2024
-
REGULATORY Japan to Add Shingles Vaccines to NIP List from FY2025, Targeting Age 65
December 19, 2024
-
ORGANIZATION JPA Calls for Improving Package Units as Pharmacies Suffer with Unsold Stocks of Pricey Meds
December 19, 2024
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
